IL146605A0 - Immunogenic peptides derived from mage and the use thereof - Google Patents

Immunogenic peptides derived from mage and the use thereof

Info

Publication number
IL146605A0
IL146605A0 IL14660500A IL14660500A IL146605A0 IL 146605 A0 IL146605 A0 IL 146605A0 IL 14660500 A IL14660500 A IL 14660500A IL 14660500 A IL14660500 A IL 14660500A IL 146605 A0 IL146605 A0 IL 146605A0
Authority
IL
Israel
Prior art keywords
mage
peptides derived
immunogenic peptides
immunogenic
derived
Prior art date
Application number
IL14660500A
Original Assignee
Genera Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genera Spa filed Critical Genera Spa
Publication of IL146605A0 publication Critical patent/IL146605A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
IL14660500A 1999-05-21 2000-05-17 Immunogenic peptides derived from mage and the use thereof IL146605A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001121A IT1312568B1 (en) 1999-05-21 1999-05-21 IMMUNOGENIC PEPTIDES AND THEIR USE.
PCT/EP2000/004465 WO2000071573A2 (en) 1999-05-21 2000-05-17 Immunogenic peptides derived from mage and the use thereof

Publications (1)

Publication Number Publication Date
IL146605A0 true IL146605A0 (en) 2002-07-25

Family

ID=11383013

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14660500A IL146605A0 (en) 1999-05-21 2000-05-17 Immunogenic peptides derived from mage and the use thereof

Country Status (10)

Country Link
EP (1) EP1179019A2 (en)
JP (1) JP2003502026A (en)
KR (1) KR20020011418A (en)
CN (1) CN1227264C (en)
AU (1) AU777474B2 (en)
CA (1) CA2374354A1 (en)
HK (1) HK1047116A1 (en)
IL (1) IL146605A0 (en)
IT (1) IT1312568B1 (en)
WO (1) WO2000071573A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235525B1 (en) * 1991-05-23 2001-05-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
US6291430B1 (en) * 1997-09-12 2001-09-18 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
US5965535A (en) * 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
AU6402099A (en) * 1998-10-29 2000-05-22 Dow Chemical Company, The Preparation of titanium(ii) or zirconium(ii) complexes

Also Published As

Publication number Publication date
WO2000071573A3 (en) 2001-04-05
IT1312568B1 (en) 2002-04-22
CA2374354A1 (en) 2000-11-30
ITMI991121A1 (en) 2000-11-21
CN1227264C (en) 2005-11-16
WO2000071573A2 (en) 2000-11-30
AU777474B2 (en) 2004-10-21
HK1047116A1 (en) 2003-02-07
CN1360595A (en) 2002-07-24
JP2003502026A (en) 2003-01-21
AU5067600A (en) 2000-12-12
KR20020011418A (en) 2002-02-08
EP1179019A2 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
HK1220483A1 (en) Neisserial antigenic peptides
IL148247A (en) Vaccine composition and uses thereof
AP2002002424A0 (en) Vaccine
IL146832A0 (en) Peptides
AU7795500A (en) Peptides which stimulate the immune response and tissue regeneration
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
HK1046925A1 (en) Mage-a12 antigenic peptides and uses thereof
MXPA02003270A (en) Novel hev antigenic peptide and methods.
EP1246635A4 (en) O-superfamily conotoxin peptides
EP1147130A4 (en) Alpha-conotoxin peptides
EP1159288A4 (en) Alpha-conotoxin peptides
GB9904695D0 (en) Peptide
GB2348359B (en) Stretchers
GB9906437D0 (en) Vaccine
IL146605A0 (en) Immunogenic peptides derived from mage and the use thereof
GB0120713D0 (en) Peptides
GB9908920D0 (en) Peptide
GB9913327D0 (en) Vaccine
HK1045173A1 (en) Polypeptide
IL145527A0 (en) Retro-inverso prosaposin-derived peptides and use thereof
EP1151100A4 (en) Tau-conotoxin peptides
GB9909072D0 (en) Vaccine
GB9907911D0 (en) Peptides
GB9928325D0 (en) Peptides
TW410603U (en) Improved urn